NeuroOne Medical Technologies this week announced its patent covering novel manufacturing steps for neural probe devices received a notice of allowance from the U.S. Patent and Trademark Office.
The patent details the arrangement of probe components and deposition of electrode contact material. NeuroOne anticipates that the patent will be issued in the coming months.
“One of the key aspects with this patent relates to the novel method of electrode material deposition for all of our electrodes that are both commercially available and in development,” CEO Dave Rosa said in a news release. “We believe that this new patent will better protect and advance our entire technology platform as we continue to develop and introduce new applications.”
The Minneapolis‑based company’s portfolio now has 17 issued and pending patents worldwide covering thin‑film neural and spinal cord electrodes designed to improve function and reduce profile. NeuroOne is developing minimally invasive, high‑definition solutions for EEG recording, ablation, drug delivery and stimulation in neurological disorders such as epilepsy and Parkinson’s disease.
